Stock CLBIO CORLINE BIOMEDICAL AB
Add to a list
To use this feature you must be a member
Log inSign up

News Corline Biomedical AB

Equities

CLBIO

SE0006887451

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-05 pm EDT 		5-day change 1st Jan Change
12.7 SEK -0.78% Intraday chart for Corline Biomedical AB -1.17% -14.77%
Apr. 30 Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Feb. 14 Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CI
Corline Biomedical AB Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Corline Biomedical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
CI
Corline Biomedical AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Corline Biomedical AB Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Corline Biomedical AB Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Corline Biomedical AB announced that it has received SEK 35.475 million in funding from M2 Asset Management AB, HealthInvest Partners AB, and other investors
CI
Corline Biomedical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
CI
Corline Biomedical AB to Enter into Agreement with the Clinical Islet Transplant Program at University of Alberta
CI
Corline Biomedical AB to Enter into Agreement with Nuffield Department of Surgical Sciences
CI
Corline Biomedical AB has completed an IPO in the amount of SEK 12.04 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CLBIO Stock
  4. News Corline Biomedical AB